ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 128 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $191,622 | -32.7% | 27,974 | +1.8% | 0.00% | – |
Q2 2023 | $284,833 | +41.3% | 27,467 | +10.2% | 0.00% | – |
Q1 2023 | $201,651 | -48.6% | 24,926 | 0.0% | 0.00% | – |
Q4 2022 | $392,585 | +6.6% | 24,926 | +6.6% | 0.00% | – |
Q3 2022 | $368,111 | +10.6% | 23,387 | -1.9% | 0.00% | – |
Q2 2022 | $332,737 | -8.9% | 23,835 | +12.5% | 0.00% | – |
Q1 2022 | $365,402 | -5.1% | 21,195 | -20.0% | 0.00% | – |
Q4 2021 | $385,000 | -19.5% | 26,495 | -0.3% | 0.00% | – |
Q3 2021 | $478,000 | +10.1% | 26,579 | +7.5% | 0.00% | – |
Q2 2021 | $434,000 | +183.7% | 24,715 | -3.5% | 0.00% | – |
Q1 2019 | $153,000 | +54.5% | 25,617 | +92.2% | 0.00% | – |
Q4 2018 | $99,000 | -35.7% | 13,329 | +25.3% | 0.00% | – |
Q3 2018 | $154,000 | -63.3% | 10,634 | -49.4% | 0.00% | – |
Q2 2018 | $420,000 | +32.5% | 21,001 | +15.8% | 0.00% | – |
Q1 2018 | $317,000 | -29.9% | 18,135 | -1.1% | 0.00% | – |
Q4 2017 | $452,000 | -0.7% | 18,333 | +4.1% | 0.00% | -100.0% |
Q3 2017 | $455,000 | +6.1% | 17,608 | +11.2% | 0.00% | 0.0% |
Q2 2017 | $429,000 | +54.3% | 15,831 | +69.7% | 0.00% | – |
Q1 2017 | $278,000 | +31.8% | 9,329 | +20.2% | 0.00% | – |
Q4 2016 | $211,000 | +9.9% | 7,762 | +3.2% | 0.00% | – |
Q3 2016 | $192,000 | +38.1% | 7,520 | 0.0% | 0.00% | – |
Q2 2016 | $139,000 | +117.2% | 7,520 | +83.0% | 0.00% | – |
Q1 2016 | $64,000 | – | 4,110 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |